Literature DB >> 31159610

The gut microbiota - a modulator of endothelial cell function and a contributing environmental factor to arterial thrombosis.

Henning Formes1, Christoph Reinhardt1,2.   

Abstract

Introduction: There is emerging evidence linking the commensal gut microbiota with the development of cardiovascular disease and arterial thrombosis. In immunothrombosis, the host clotting system protects against the dissemination of invading microbes, not considering the huge number of microbes that interact with host physiology in a mutualistic fashion. Areas covered: Interestingly, recent research revealed that colonizing gut microbes profoundly influence host innate immune pathways that support arterial thrombus growth. The gut microbiota promotes arterial thrombus formation by enhancing the pro-adhesive capacity of the vascular endothelium, triggering hepatic von Willebrand factor synthesis and its release by Weibel-Palade body exocytosis, resulting in elevated von Willebrand factor levels and enhancing FVIII stability in plasma. Furthermore, the metabolic capacity of gut resident microbes promotes agonist-induced platelet activation and deposition. Here, we give an overview, with a focus on the vascular endothelium, on how this gut-resident microbial ecosystem contributes to arterial thrombus formation. Expert opinion: The gut microbiota and its metabolites not only act on agonist-induced platelet reactivity, but also influence the hepatic endothelial phenotype via remote signaling, facilitating arterial thrombus growth at the arterial injury site.

Entities:  

Keywords:  Microbiota; arterial thrombosis; cardiovascular disease; endothelial cell; germ-free mouse model; immunothrombosis; platelets; toll-like receptor; trimethylamine N-oxide; von Willebrand factor

Mesh:

Substances:

Year:  2019        PMID: 31159610     DOI: 10.1080/17474086.2019.1627191

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  3 in total

Review 1.  The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis.

Authors:  Anna Lässiger-Herfurth; Giulia Pontarollo; Alexandra Grill; Christoph Reinhardt
Journal:  Microorganisms       Date:  2019-12-13

Review 2.  Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases.

Authors:  Anna Oniszczuk; Tomasz Oniszczuk; Marek Gancarz; Jolanta Szymańska
Journal:  Molecules       Date:  2021-02-22       Impact factor: 4.411

3.  Antithrombotic Activity of Heparinoid G2 and Its Derivatives from the Clam Coelomactra antiquata.

Authors:  Guanlan Chen; Rui Zeng; Xin Wang; Hongying Cai; Jiajia Chen; Yingxiong Zhong; Saiyi Zhong; Xuejing Jia
Journal:  Mar Drugs       Date:  2022-01-05       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.